Kazuma Okada

Dr. Kazuma Okada

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
ASAshish Sethi
Ashish Sethi
SRStephen M. Rawlinson
Stephen M. Rawlinson
ADAbhinav Dubey
Abhinav Dubey
CAChing-Seng Ang
Ching-Seng Ang
YCYoon Hee Choi
Yoon Hee Choi
PGPaul Gooley
Paul Gooley
Viruses form extensive interfaces with host proteins to modulate the biology of the infected cell, frequently via multifunctional viral proteins. These proteins are conventionally considered as assemblies of independent functional modules, where the presence or absence of modules determines the overall composite phenotype. However, this model cannot account for functions observed in specific viral proteins. For example, rabies virus (RABV) P3 protein is a truncated form of the pathogenicity factor P protein, but displays a unique phenotype with functions not seen in longer isoforms, indicating that changes beyond the simple complement of functional modules define the functions of P3. Here, we report structural and cellular analyses of P3 derived from the pathogenic RABV strain Nishigahara (Nish) and an attenuated derivative strain (Ni-CE). We identify a network of intraprotomer interactions involving the globular C-terminal domain and intrinsically disordered regions (IDRs) of the N-terminal region that characterize the fully functional Nish P3 to fluctuate between open and closed states, whereas the defective Ni-CE P3 is predominantly open. This conformational difference appears to be due to the single mutation N226H in Ni-CE P3. We find that Nish P3, but not Ni-CE or N226H P3, undergoes liquid–liquid phase separation and this property correlates with the capacity of P3 to interact with different cellular membrane-less organelles, including those associated with immune evasion and pathogenesis. Our analyses propose that discrete functions of a critical multifunctional viral protein depend on the conformational arrangements of distant individual domains and IDRs, in addition to their independent functions.

23 July 2024 in Journal of Virology
Verified
Journal Article
Closed access
JHJunki Hirano
Junki Hirano
THTsuyoshi Hayashi
Tsuyoshi Hayashi
KKKouichi Kitamura
Kouichi Kitamura
YNYorihiro Nishimura
Yorihiro Nishimura
HSHiroyuki Shimizu
Hiroyuki Shimizu
YMYoshiharu Matsuura
Yoshiharu Matsuura
Enteroviruses are single-stranded, positive-sense RNA viruses causing endoplasmic reticulum (ER) stress to induce or modulate downstream signaling pathways known as the unfolded protein responses (UPR). However, viral and host factors involved in the UPR related to viral pathogenesis remain unclear. In the present study, we aimed to identify the major regulator of enterovirus-induced UPR and elucidate the underlying molecular mechanisms. We showed that host Golgi-specific brefeldin A-resistant guanine nucleotide exchange factor 1 (GBF1), which supports enteroviruses replication, was a major regulator of the UPR caused by infection with enteroviruses. In addition, we found that severe UPR was induced by the expression of 3A proteins encoded in human pathogenic enteroviruses, such as enterovirus A71, coxsackievirus B3, poliovirus, and enterovirus D68. The N-terminal-conserved residues of 3A protein interact with the GBF1 and induce UPR through inhibition of ADP-ribosylation factor 1 (ARF1) activation via GBF1 sequestration. Remodeling and expansion of ER and accumulation of ER-resident proteins were observed in cells infected with enteroviruses. Finally, 3A induced apoptosis in cells infected with enteroviruses via activation of the protein kinase RNA-like endoplasmic reticulum kinase (PERK)/C/EBP homologous protein (CHOP) pathway of UPR. Pharmaceutical inhibition of PERK suppressed the cell death caused by infection with enteroviruses, suggesting the UPR pathway is a therapeutic target for treating diseases caused by infection with enteroviruses. IMPORTANCE: Infection caused by several plus-stranded RNA viruses leads to dysregulated ER homeostasis in the host cells. The mechanisms underlying the disruption and impairment of ER homeostasis and its significance in pathogenesis upon enteroviral infection remain unclear. Our findings suggested that the 3A protein encoded in human pathogenic enteroviruses disrupts ER homeostasis by interacting with GBF1, a major regulator of UPR. Enterovirus-mediated infections drive ER into pathogenic conditions, where ER-resident proteins are accumulated. Furthermore, in such scenarios, the PERK/CHOP signaling pathway induced by an unresolved imbalance of ER homeostasis essentially drives apoptosis. Therefore, elucidating the mechanisms underlying the virus-induced disruption of ER homeostasis might be a potential target to mitigate the pathogenesis of enteroviruses.

2 January 2023 in Journal of Clinical Virology
Verified
Journal Article
Open access
DKDaiki Kanbayashi
Daiki Kanbayashi
TKTakako Kurata
Takako Kurata
AKAtsushi Kaida
Atsushi Kaida
HKHideyuki Kubo
Hideyuki Kubo
SYSeiji P. Yamamoto
Seiji P. Yamamoto
KIKazuyoshi Ikuta
Kazuyoshi Ikuta
Since the first isolation of rubella virus (RuV) in 1962, comprehensive data regarding the quantitative evaluation of RuV shedding remain unavailable. In this study, we evaluated the shedding of viral RNA and infectious virus in patients with acute RuV infection. We analyzed 767 specimens, including serum/plasma, peripheral blood mononuclear cells (PBMCs), throat swabs, and urine, obtained from 251 patients with rubella. The viral RNA load and the presence of infectious RuV were determined using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and virus isolation. Virus excretion peaked 0-2 days after rash onset and decreased over time. The median viral RNA load dropped to an undetectable level on day 3 after rash onset in serum/plasma, day 2 in PBMCs, days 10-13 in throat swabs, and days 6-7 in urine. Infectious virus could be isolated for up to day 2 after rash onset in serum/plasma, day 1 in PBMCs, days 8-9 in throat swabs, and days 4-5 in urine. The minimum viral RNA load that allowed virus isolation was 961 copies/mL in serum/plasma, 784 copies/mL in PBMCs, 650 copies/mL in throat swabs, and 304 copies/mL in urine. A higher viral RNA load indicated a higher likelihood of the presence of infectious virus. These findings would contribute to improve algorithms for rubella surveillance and diagnosis. In addition, this study indicates that the results of RT-qPCR enable efficient rubella control by estimating candidate patients excreting infectious virus, which could help prevent viral transmission at an early stage and eliminate rubella ultimately.

19 November 2021 in Viruses
Verified
Journal Article
Open access
PDF file
KYKohei Yumoto
Kohei Yumoto
TATomoaki Arisaka
Tomoaki Arisaka
KOKazuma Okada
Kazuma Okada
KAKyosuke Aoki
Kyosuke Aoki
TOToyoyuki Ose
Toyoyuki Ose
KMkatsumi maenaka
katsumi maenaka
Rabies has almost a 100% case-fatality rate and kills more than 59,000 people annually around the world. There is no established treatment for rabies. The rabies virus (RABV) expresses only the glycoprotein (RABVG) at the viral surface, and it is the target for the neutralizing antibodies. We previously established mouse monoclonal antibodies, 15–13 and 12–22, which showed neutralizing activity against the RABV, targeting the sequential and conformational epitopes on the RABVG, respectively. However, the molecular basis for the neutralizing activity of these antibodies is not yet fully understood. In this study, we evaluated the binding characteristics of the Fab fragments of the 15–13 and 12–22 antibodies. The recombinant RABVG protein, in prefusion form for the binding analysis, was prepared by the silkworm–baculovirus expression system. Biolayer interferometry (BLI) analysis indicated that the 15–13 Fab interacts with the RABVG, with a KD value at the nM level, and that the 12–22 Fab has a weaker binding affinity (KD ~ μM) with the RABVG compared to the 15–13 Fab. Furthermore, we determined the amino acid sequences of both the antibodies and the designed single-chain Fv fragments (scFvs) of the 15–13 and 12–22 antibodies as another potential biopharmaceutical for targeting rabies. The 15–13 and 12–22 scFvs were successfully prepared by the refolding method and were shown to interact with the RABVG at the nM level and the μM level of the KD, respectively. These binding characteristics were similar to that of each Fab. On the other hand, differential scanning fluorometry (DSF) revealed that the thermal stability of these scFvs decreases compared to their Fabs. While the improvement of the stability of scFvs will still be required, these results provide insights into the neutralizing activity and the potential therapeutic use of antibody fragments for RABV infection.

21 April 2026 in Journal of Virology
Verified
Journal Article
Open access
JHJunki Hirano
Junki Hirano
THTsuyoshi Hayashi
Tsuyoshi Hayashi
YSYuichi Someya
Yuichi Someya
KOKazuma Okada
Kazuma Okada
KUKentaro Uemura
Kentaro Uemura
YMYoshiharu Matsuura
Yoshiharu Matsuura
Picornaviruses represent a diverse group of plus-stranded RNA viruses, many of which have been linked to severe diseases in both humans and animals. The viral 3C protease is essential for the maturation of viral proteins and the propagation of picornaviruses and, owing to its cleavage activity against multiple host proteins, is associated with the pathogenesis of picornaviruses. The picornaviral 3C protease is an ideal drug target for inhibiting viral propagation and mitigating pathogenesis; however, methodology to evaluate and compare the activity of phylogenetically diverse proteases remains lacking. To address this, herein, we propose a novel green fluorescent protein (GFP)-based reporter optimized to visualize the enzymatic activity of picornaviral 3C proteases in cells by using the conformational change of a GFP variant induced by the 3C protease, generating fluorescence emission linked to the enzymatic activity. Upon treatment of picornaviruses with a known 3C protease inhibitor, the fluorescence decreased in a dose-dependent manner, demonstrating that the signal depended on the activity of the 3C protease. The reporter system for the 3C protease can be applied to major pathogenic human picornaviruses, such as those in the genera Enterovirus , Rhinovirus , Cosavirus , Salivirus, and Kobuvirus . Furthermore, the fluorescent signal from the reporter was confirmed in various animal-derived picornaviruses, such as those from bats, rodents, and primates. Therefore, the reporter could be widely used to analyze the activity of several 3C proteases from currently prevalent picornaviruses and those that may emerge in the future. To demonstrate the flexibility of the reporter in comparing phylogenetically different proteases, the enzymatic activity of the 3C protease derived from clinical strains of enterovirus A71 (EV-A71) was tested and compared. Using the reporter assay, we identified amino acid variations that modulate 3C protease activity. Additionally, we observed that the 3C proteases from distinct EV-A71 strains exhibited differential efficiency in cleaving host proteins. Our findings will aid in elucidating the molecular characteristics of 3C proteases among picornaviruses and developing therapeutics to mitigate the pathogenesis of these viruses. IMPORTANCE: The family Picornaviridae comprises various biologically distinct viruses that have been linked to life-threatening diseases, including emerging and previously neglected pathogens whose molecular characteristics remain elusive. Although the viral protease encoded by picornaviruses, the 3C protease, is an ideal target for anti-picornaviral pharmacological intervention, the current assay system for evaluating the activity of 3C proteases remains limited to a few specific picornaviruses. To address this, we sought to establish a flexible and straightforward protocol for assessing and comparing various picornaviral 3C proteases. We developed a cell-based assay for 3C proteases using a split-green fluorescent protein (GFP) variant with a specific viral sequence that could be applied to a wide range of human pathogenic and animal-derived picornavirus strains. Furthermore, by swapping the viral sequence inside GFP for a host-derived sequence, this assay could be used to evaluate the 3C protease activity of cleaving host proteins. This assay will facilitate future research comparing functional differences of 3C proteases among picornaviruses, conducting high-throughput screening of anti-picornaviral drugs, or investigating the relationship between protease activity and picornaviral pathogenesis.

31 July 2025 in bioRxiv
Verified
Preprint
Open access
JHJunki Hirano
Junki Hirano
THTsuyoshi Hayashi
Tsuyoshi Hayashi
YSYuichi Someya
Yuichi Someya
KOKazuma Okada
Kazuma Okada
KUKentaro Uemura
Kentaro Uemura
YMYoshiharu Matsuura
Yoshiharu Matsuura
Picornaviruses represent a diverse group of plus-stranded RNA viruses, many of which have been linked to severe diseases in both humans and animals. The viral 3C protease is essential for the maturation of viral proteins and the propagation of picornaviruses and, owing to its cleavage activity against multiple host proteins, is associated with the pathogenesis of picornaviruses. The picornaviral 3C protease is an ideal drug target for inhibiting viral propagation and mitigating pathogenesis; however, methodology to evaluate and compare the activity of phylogenetically diverse proteases remains lacking. To address this, herein, we propose a novel green fluorescent protein (GFP)-based reporter optimized to visualize the enzymatic activity of picornaviral 3C proteases in cells by using the conformational change of a GFP variant induced by the 3C protease, generating fluorescence emission linked to the enzymatic activity. Upon treatment of picornaviruses with a known 3C protease inhibitor, the fluorescence decreased in a dose-dependent manner, demonstrating that the signal depended on the activity of the 3C protease. The reporter system for the 3C protease can be applied to major pathogenic human picornaviruses, such as those in the genera Enterovirus , Rhinovirus , Cosavirus , Salivirus, and Kobuvirus . Furthermore, the fluorescent signal from the reporter was confirmed in various animal- derived picornaviruses, such as those from bats, rodents, and primates. Therefore, the reporter could be widely used to analyze the activity of several 3C proteases from currently prevalent picornaviruses and those that may emerge in the future. To demonstrate the flexibility of the reporter in comparing phylogenetically different proteases, the enzymatic activity of the 3C protease derived from clinical strains of enterovirus A71 (EV-A71) was tested and compared. The results showed that the amino acid residues of the 3C protease affect its activity by utilizing the reporter system. Additionally, clinical EV- A71 strains had different effects on the activity of 3C protease against host proteins. Our findings will aid in elucidating the molecular characteristics of 3C proteases among picornaviruses and developing therapeutics to mitigate the pathogenesis of these viruses.